Runben Biotechnology Co., Ltd. (SHA:603193)
21.25
+0.57 (2.76%)
Aug 25, 2026, 3:00 PM CST
-31.76% (1Y)
| Market Cap | 8.37B -33.6% |
| Revenue (ttm) | 1.70B +15.9% |
| Net Income | 352.07M +14.4% |
| EPS | 0.88 +15.7% |
| Shares Out | 404.59M |
| PE Ratio | 23.52 |
| Forward PE | 22.24 |
| Dividend | 0.46 (2.26%) |
| Ex-Dividend Date | May 29, 2026 |
| Volume | 5,425,604 |
| Open | 20.54 |
| Previous Close | 20.68 |
| Day's Range | 20.38 - 21.55 |
| 52-Week Range | 17.77 - 31.10 |
| Beta | 0.18 |
| Analysts | Strong Buy |
| Price Target | 31.18 (+46.73%) |
| Earnings Date | Aug 21, 2026 |